HER2 Support Group Forums - View Single Post - targeting of erbB3 with MM-121/SAR256212 enhances paclitaxel

'lizbeth · 10-29-2013, 10:56 AM

Thanks Hopeful,

I'm always on the lookout for unicorns. I found Merrimack Pharma's pipeline and see they also have MM302 in the pipeline for advanced Her2 breast cancer:

MM-302 (Nanotherapeutic)

Indication:
Description:
Target

Advanced HER2+ breast cancer
Antibody targeted nanotherapeutic
HER2-targeted encapsulated doxorubicin

MM-302 is a HER2-targeted nanotherapeutic consisting of the chemotherapeutic doxorubicin, encapsulated in a liposomal sphere. Doxorubicin has been a standard therapy for the treatment of breast cancer for more than 30 years.

Doxorubicin is also known as Doxil, or Adriamycin.

10-29-2013, 10:56 AM	#2
'lizbeth Senior Member Join Date: Apr 2008 Location: Sunny San Diego Posts: 2,214	Re: targeting of erbB3 with MM-121/SAR256212 enhances paclitaxel Thanks Hopeful, I'm always on the lookout for unicorns. I found Merrimack Pharma's pipeline and see they also have MM302 in the pipeline for advanced Her2 breast cancer: MM-302 (Nanotherapeutic) Indication: Description: Target Advanced HER2+ breast cancer Antibody targeted nanotherapeutic HER2-targeted encapsulated doxorubicin MM-302 is a HER2-targeted nanotherapeutic consisting of the chemotherapeutic doxorubicin, encapsulated in a liposomal sphere. Doxorubicin has been a standard therapy for the treatment of breast cancer for more than 30 years. Doxorubicin is also known as Doxil, or Adriamycin.